share_log

EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis

EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis

獨家報道:Pasithea Treateutics宣佈臨牀前研究結果表明,耐受疫苗對復發-緩解型多發性硬化症有效
Benzinga Real-time News ·  2022/08/11 07:30

EXCLUSIVE: Pasithea Therapeutics Announces Results Of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy In Relapsing-Remitting Model Multiple Sclerosis

獨家報道:Pasithea Treateutics宣佈臨牀前研究結果表明,耐受疫苗對復發-緩解型多發性硬化症有效

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論